Cas:97-53-0 Eugenol manufacturer & supplier

We serve Chemical Name:Eugenol CAS:97-53-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Eugenol

Chemical Name:Eugenol
CAS.NO:97-53-0
Synonyms:4-Allyl-2-methoxyphenol;Eugenic acid;p-Allylguaiacol;2-methoxy-4-allyl phenol;2-methoxy-4-(prop-2-en-1-yl)phenol;Eugenol;2U1R DQ CO1;4-allylguaiacol;2-methoxy-4-(2-propen-1-yl)phenol;p-Eugenol;femano.2467;EINECS 202-589-1;1-allyl-4-hydroxy-3-methoxybenzene;2-Methoxy-4-allylphenol;Engenol;FA 100;Caryophyllic acid;FEMA 2467;Phenol, 2-methoxy-4-(2-propen-1-yl)-;MFCD00008654
Molecular Formula:C10H12O2
Molecular Weight:164.201
HS Code:29095090

Physical and Chemical Properties:
Melting point:−12-−10 °C(lit.)
Boiling point:255.0±0.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.536
PSA:29.46000
Exact Mass:164.083725
LogP:2.20

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 4-Allyl-2-methoxyphenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00008654 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Engenol Use and application,Phenol, 2-methoxy-4-(2-propen-1-yl)- technical grade,usp/ep/jp grade.


Related News: The client needed full development and product readiness with an extremely short supply of the API. In addition, the scale-up batch was small because of the low volume of product demands of their orphan drug. chryseno[6,5-d]oxazole manufacturers Sales for Tafinlar and Mekinist, the MEK inhibitor it was approved with, hit $672 million in 2016. Fast forward to 2020 and the duo generated $1.5 billion in revenue. Cardiolipin synthetase (Listeria monocytogenes strain 4b F2365 genecls-1) suppliers Recipharm joined the COVID-19 fight in December, signing on to produce the Moderna vaccine at its plant in Monts, France. The company hasn’t revealed if the new facilities will be engaged in COVID-19 vaccine production, though the plant in Morocco will “mirror” a new fill-finish line it added in France. 2-Benzamino-2-(2-methyl-phenylhydrazono)-essigsaeureamid vendor & factory Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial.,“His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement.